An examination of imaging findings in patients with clinically diagnosed gluteal tendinopathy: a secondary analysis of a randomised clinical trial

对临床诊断为臀肌腱病患者的影像学表现进行分析:一项随机临床试验的二次分析

阅读:1

Abstract

OBJECTIVES: To report tendon pathology present on imaging and relationships to pain, function and disability in participants with gluteal tendinopathy (GT) who participated in a multi-centre randomised clinical trial. MATERIALS AND METHODS: Imaging findings were examined in 204 participants with GT. Magnetic Resonance Images (MRI) and x-ray were evaluated against pre-determined criteria by experienced radiologists, blind to clinical findings, who reported on location of tendon pathology, presence and severity of tendon tears and location and presence of calcification. Severity of changes seen on MRI were scored and analyses for relationships to pain, function and disability were performed. RESULTS: Information on location and severity of tendon pathology was available for 202 (99%) of the 204 LEAP trial participants. Tendon pathology was commonly present in both the gluteus medius (GMed) and gluteus minimus (GMin) tendons (130/202; 64%), with tears in one or both tendons in 85 (42%) participants. Of 99 tears across both tendons, 77 (78%) were partial-thickness and 22 (22%) were full-thickness in nature. The anterior aspect of the GMed tendon and the posterior aspect of the GMin tendon were most afflicted. Calcifications at the lateral ilium or greater trochanter were evident on x-ray in 73 (36%) participants. Pain, function and disability were not associated with the severity of changes on MRI. CONCLUSION: In a clinical trial of people with GT, a substantial number of participants had multiple tendons affected, as well as concomitant tendon tears and calcification. MRI detected changes were not associated with levels of pain, function or disability.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。